Bright light therapy for gut inflammation in Crohn’s or colitis
Part of Digestive system clinical trials.
This trial studies whether daily bright light can improve gut barrier “leakiness” and reduce inflammation in adults with Crohn’s disease or ulcerative colitis. It compares bright light versus dim light in a crossover design, meaning you may receive both.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Crohn’s disease or ulcerative colitis confirmed by biopsy
- You are 18 years or older
- You currently have signs of active gut inflammation (from stool/blood tests) or high fatigue
- You have been on a stable Crohn’s/colitis medication plan for at least 12 weeks
- You can give informed consent and understand study procedures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether morning light therapy can help reduce inflammation in people with ulcerative colitis. It may be an option if you have active inflammation and can attend light sessions.
This study tests a new investigational drug (called LMT503) for the first time in humans, in healthy volunteers. It is a phase 1 trial that will look at how the body processes the drug and its safety, including how it behaves in the blood. The trial involves taking the drug once (single dose) or multiple times over several days, with close monitoring by the research team.
This trial studies whether eating a Mediterranean-style diet can improve inflammatory bowel disease (including mild to moderate Crohn’s). It may help by testing changes in gut inflammation measured by your symptoms and stool tests.
This trial tests a new infrared light treatment to see if it can reduce inflammation and symptoms in people with Crohn's disease. It's for those who have active disease despite current treatments or who are not on therapy.
This study tests a new way to see inflammation in the gut during a colonoscopy by using special dye attached to two IBD medications (adalimumab and risankizumab). The dye makes the medication glow under a special camera, which may help doctors see exactly where and how much inflammation is present, potentially guiding better treatment.
This trial tests new therapies for people with moderate to severe Crohn's disease or ulcerative colitis. It may help if your standard treatments aren't working well enough.
Hear when a new Inflammatory Bowel Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.